Find an expert

I am a medicinal chemist and postdoctoral research fellow at the University of Queensland, Australia, where I obtained my BSc (Hons) with a major in organic chemistry in 2011. Following this, I worked at the Institute for Future Environments and later the Centre for Tropical Crops and Biocommodities at QUT, where I gained experience in analytical chemistry, as well as molecular biology and genetics. In 2015, I returned to UQ to begin my PhD in the design and synthesis of novel antifungals targeting invasive infection under the supervision of Prof. Craig Williams and Prof. Luke Guddat, which I completed in 2019. Since this time I have worked at the School of Chemistry and Molecular Biosciences as a Postdoctoral Research Fellow under the supervision of Prof. Craig Williams, Prof. Avril Robertson, and now Prof. James De Voss. Broadly, my research interests lie in the pursuit of drug design and development campaigns addressing difficult or under-researched clinical concerns, and in particular, the use of novel bioisosteric approaches to improve drugability and drug efficacy.

More recently, I have developed an interest in Australian mushroom species. Very little recorded knowledge on our endemic mushrooms species exists. My research in this space seeks to characterise the genetic and molecular features of Australian wood rot mushrooms, which are critical players in maintaining and restoring the health of our unique forests ecosystems. With this information we aim to better understand our fungal biodiversity and the ecological roles they play, and to explore their potential as a platform for the identification of new drug molecules.

Prof David Ascher is an NHMRC Investigator Leadership Fellow and Deputy Associate Dean (Research Partnerships) in the Faculty of Science at The University of Queensland. He also serves as Deputy Director of the Australian Centre for Ecogenomics and Head of Computational Biology & Clinical Informatics at the Baker Heart and Diabetes Institute. Internationally, he sits on scientific advisory boards for A*STAR (Singapore), Fiocruz (Brazil) and the Tuscany University Network (Italy), and has been recognised with major honours including the Royal Society of Chemistry Horizon Prize.

A global leader in computational biology and personalised medicine, Prof Ascher develops advanced AI- and structure-based approaches to understand how genetic variation alters protein structure, function, and clinical outcomes. His group has built one of the world’s most widely used platforms for interpreting coding variants—over 90 computational tools, accessed more than 9.5 million times per year from 120+ countries. These tools underpin clinical diagnostics, guide drug development pipelines, and support international public-health responses to antimicrobial resistance and emerging infectious diseases.

His research has led to new molecular insights across infectious disease, rare disease, oncology and cardiometabolic health, and has been translated directly into practice—informing WHO policy, enabling early resistance detection in tuberculosis and leprosy, stratifying patients with hereditary cancers, and supporting vaccine design with partners including Pfizer. Many of his methods are embedded in globally used resources such as Ensembl VEP, PDBe, and the EMBL-EBI KnowledgeBase.

Prof Ascher has a longstanding commitment to interdisciplinary leadership and capability-building across UQ. As Director (Strategy) of the Biotechnology Programs and later as Deputy Associate Dean (Research Partnerships), he has driven initiatives to transform UQ’s biotechnology education, grow industry-embedded training, expand international partnerships, and diversify research income. He has led the development of UQ’s biotechnology–industry placement ecosystem, initiated new professional development programs adopted across multiple Faculties and Institutes, and established major collaborations with government, industry and global research organisations.

He has published more than 250 peer-reviewed papers (over half as senior author: FWCI 2.7), secured more than $30M in competitive research funding, and supervised over 60 HDR students who now hold leadership positions in academia, industry and government. His work appears in leading journals including Nature, Nature Genetics, Science, PNAS and Nature Microbiology, and is cited in over 100 policy documents and 40 patents.

Prof Ascher holds degrees in Biotechnology, Biochemistry, Structural Biology and Law. His research career has spanned Adelaide, Melbourne, Cambridge and Brisbane. After his PhD with Professor Michael Parker, he worked with Sir Tom Blundell at the University of Cambridge, where he led programs in structure-guided drug discovery and protein–protein interaction targeting. He established his independent laboratory at Cambridge and then at the University of Melbourne/Bio21 Institute, before moving to the Baker Institute in 2019 and joining UQ in 2021.

Dr Melinda Ashcroft is a Research Fellow on Infectious Disease Epidemiology (Climate Change) in the Faculty of Medicine at The University of Queensland (UQ). Her current research focus is on Nontuberculous mycobacteria (NTM) and how NTM infections are associated with climate change and major weather events. Previously Melinda has worked at Monash University as a Research Fellow on the Sero-epidemiology of Klebsiella spp., at the University of Melbourne as a Postdoctoral Research Fellow on the Genomic Epidemiology of Neisseria gonorrhoeae and as a Research Associate at UQ on the genomics and epigenomics of extraintestinal pathogenic Escherichia coli. Melinda was awarded a Bachelor of Applied Science (Biotechnology/Biochemistry) in 2004 from Queensland University of Technology and a Master of Biotechnology in 2013 from UQ. She then switched fields to Microbial Genomics and was awarded a PhD from UQ in 2019 for her thesis: Evolution and function of mobile genetic elements and DNA methyltransferases in extraintestinal pathogenic Escherichia coli.

Scott Beatson is an Associate Professor and NHMRC Career Development Fellow at The University of Queensland (UQ). He specializes in bacterial pathogenomics: using whole-genome sequencing to investigate transmission, pathogenesis and antibiotic resistance in bacteria. Recent work from his group includes genomic analyses of pandrug resistant enterobacteriaceae and the multidrug resistant Escherichia coli ST131 pandemic clone. He was awarded a PhD from UQ for his work in bacterial pathogenesis in 2002 and developed his career in bacterial genomics in the United Kingdom with the support of fellowships from the Royal Commission for the Exhibition of 1851 (University of Oxford) and the UK Medical Research Council (University of Birmingham). Since returning to Australia he has held fellowships from both the NHMRC and ARC and has led a successful research group in the School of Chemistry and Molecular Biosciences at UQ since 2008. He is also a member of the Australian Infectious Diseases Research Centre and the Australian Centre for Ecogenomics. In 2016 he received the Frank Fenner Award from the Australian Society for Microbiology in recognition of his contribution to microbiology research in Australia.

As a teaching and research academic within the School of the Environment at the University of Queensland, I research the biology and genetics of mosquitoes in our region of the Indo-Pacific that delivers fundamental knowledge into the role mosquitoes play in mosquito-borne disease. This work moves across basic and applied research and has advanced our understanding of mosquitoes, their evolution, species’ distributions, permitting better focused mosquito control to be imagined. More recent research involves exploring new environmentally friendly biological control tools such as using the Wolbachia bacterium and genetic modification to combat mosquito-borne disease.

For more detail on my research please see below and at this link http://www.nigelbeebe.com

Associate Professor Jakob Begun is the IBD Group leader in the Immunity, Infection, and Inflammation Program at Mater Research University of Queensalnd, and has a basic and translational laboratory at the Translational Research Institute in Brisbane. He is an Associate Professor in the University of Queensland Faculty of Medicine. After completing his Bachelor of Science at Cornell University Jakob attended Cambridge University where he completed an MPhil in Biochemistry. He then moved on to Harvard Medical School where he completed his MD and PhD in genetics studying the host pathogen interaction using C. elegans as a model system. He completed his clinical training in internal medicine at Brigham and Women’s hospital and went on to complete general gastroenterology training at Massachusetts General Hospital (MGH) as well as advanced training in the treatment of Inflammatory Bowel Disease (IBD).

Dr Begun first joined Mater Research - University of Queensland in 2014, and at the same time received a clinical staff appointment in Gastroenterology at the Mater Hospital Brisbane. His clinical activities are focussed on the treatment and mangement of patients with IBD. He is the director of the IBD unit at the Mater Hospital Brisbane and at the Mater Young Adult Health Centre Brisbane .In January 2015 he was awarded the University of Queensland Reginald Ferguson Fellowship in Gastroenterology to support his research activity. He leads a basic and translational laboratory at the Translational Research Institute investigating the interaction between the innate immune system and the gut microbiome, as well as genetic contributions to disease. He also performs clinical research examining predictors of response to therapy, minimising barriers of care for adolescents and young adults with IBD, improving outcomes in pregnancy and IBD, and the use of intestinal ultrasound in IBD. He is the chair of the Gastroenterology Society of Australia-IBD Faculty and of the president of the Gastroenterology Network of Intestinal Ultrasound (GENIUS).

My research interests are in evolutionary quantitative genetics. Much of my research involves developing multivariate statistical approaches to the analysis of the genetic basis of complex traits, and the selection acting upon them, which are then applied to questions in statistical genetics and evolutionary biology. Many of the empirical studies I conduct use the Australian native model system Drosophila serrata.

Mikael Bodén has a PhD in Computer Science and statistical machine learning from the University of Exeter (UK) but has spent the last decade and a half in biological research environments, including the Institute for Molecular Bioscience/ARC Centre of Excellence in Bioinformatics and the School of Chemistry and Molecular Biosciences, where he is currently located. He is the director of UQ’s postgraduate program in bioinformatics. Mikael Bodén has supervised 7 postdocs from funding he received from both ARC and NHMRC; he has been the primary advisor for 11 PhD and 3 MPhil graduates; he is currently supervising another 6 PhD students in bioinformatics and computational biology. Mikael Bodén collaborates with researchers in neuroscience, developmental biology, protein engineering and bioeconomy to mention but a few, and contributes expertise in the processing, analysis and integration of biological data; this is exemplified by recent publications in Science, Nature Catalysis, Nature Communications, Cell Systems, Nucleic Acids Research and Bioinformatics.

Research in the Bredy laboratory is aimed at elucidating how the genome is connected to the environment through epigenetic modifications, and how this relationship shapes brain and behaviour throughout life. The group is particularly interested in how epigenetic mechanisms, including DNA methylation, histone modifications. the activity of non-coding RNAs, and RNA modification regulate the formation and maintenance of associative fear-related memory.

Dr Sandra Brosda is a Research Fellow within the Surgical Oncology group led by Professor Andrew Barbour.

Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the University of Queensland in November 2020. Her research focuses on biomarker discovery and intra-tumour heterogeneity and tumour evolution in oesophageal adenocarcinoma (OAC). In 2021, Dr Brosda was awarded a Cure Cancer Australia PdCCRS grant and an MSH project grant to further investigate tumour evolution to improve precision medicine in OAC.

She has been involved in research projects covering genetics, epigenetics, spatial transcriptomics, radiomics, ctDNA and quality of life assessments in the context of cancer. Overall, her research applies bioinformatics tools and approaches to cancer genomics to improve precision medicine and health outcomes for patients with melanoma, oesophago-gastric cancer and pancreatic cancer.

Melissa is no longer active in research, and so is unable to supervise new students.

BIOGRAPHY

Melissa Brown completed her PhD at the Walter and Eliza Hall Institute in Melbourne in 1993, on the structure and regulation of genes encoding colony-stimulating factor receptors in human leukaemia.

She then undertook postdoctoral training at the Imperial Cancer Research Fund (now Cancer Research UK) in London, funded firstly by an EMBO and then by an ICRF postdoctoral fellowship, working on the isolation and characterization of the first breast cancer susceptibility gene, BRCA1.

She joined The University of Queensland in 2000 as a Lecturer and is now a Professor and Executive Dean. In 2005 she undertook a six-month sabbatical at the Sir William Dunn School of Pathology at The University of Oxford.

The focus of Melissa’s research is cancer genetics, in particular understanding the transcriptional and post-transcriptional regulation of breast cancer genes and the impact of genetic variants on cancer risk and progression.

Dr Bradley Campbell has over 10 years’ experience in plant biotechnology research and since 2003 has held research positions focused on plant molecular genetics. His research involves the use of genomic tools for crop improvement, with an emphasis on the sustainable production of grain crops. Major focus is on the improvement of crops for food, feed and bio-industrial end-uses. For the past 5 years he has also been involved in hay fever studies, focused on metagenomics of the aerobiome of Australian climates and its links to allergy. Current projects involve the genotyping of the Pacific Islands in vitro taro collection for germplasm preservation and breeding purposes, investigation into infrared spectral cameras and their applicability to taro salinity screening, as well as a comphrehensive bio-geographic analysis of the urban Australian aerobiome and its links to allergic rhinitis.

Dr Chan has a PhD in Genomics and Computational Biology from UQ. He underwent postdoctoral training at Rutgers University (USA) in algal genomics and evolution. He returmed to UQ in late 2011 as one of the inaugural Great Barrier Reef Foundation Bioinformatics Fellows.

Dr Chan joined the School of Chemistry and Molecular Biosciences in 2020 as a group leader at the Australian Centre for Ecogenomics (ACE). His group uses advanced computational approaches to study genome evolution and develop scalable approaches for comparative genomics.

Summary of Research:

• My current research at UQ is as Professor in this School (teaching AGRC3040 Crop Physiology) and as an Affiliate Professor of QAAFI. Since 2020, with full-time appointment at UQ, my research portfolio has included multiple projects in applications of machine learning and artificial intelligence into the ag domain. This area is developing rapidly and across UQ, I am engaging with faculty in multiple schools (ITEE, Maths and Physics, Mining and Mech Engineering) as well as in the Research Computing Centre to develop new projects and training opportunities at the interface of field agriculture and these new digital analytics.
• My career research has been around genetic and environment effects on physiology of field crops, particularly where drought dominates. Application of quantitative approaches (crop simulation and statistical methods) and phenotyping (aerial imaging, canopy monitoring) to integrate the understanding of interactions of genetics, growth and development and the bio-physical environment on crop yield. In recent years, this work has expanded more generally into various applications in digital agriculture from work on canopy temperature sensing for irrigation decisions (CSIRO Entrepreneurship Award 2022) through to applications of deep-learning to imagery to assist breeding programs.
• Much of this research was undertaken with CSIRO since 1996. Building on an almost continuous collaboration with UQ over that time, including as an Adjunct Professor to QAAFI, Prof Chapman was jointly appointed (50%) as a Professor in Crop Physiology in the UQ School of Agriculture and Food Sciences from 2017 to 2020, and at 100% with UQ from Sep 2020. He has led numerous research projects that impact local and global public and private breeding programs in wheat, sorghum, sunflower and sugarcane; led a national research program on research in ‘Climate-Ready Cereals’ in the early 2010s; and was one of the first researchers to deploy UAV technologies to monitor plant breeding programs. Current projects include a US DoE project with Purdue University, and multiple projects with CSIRO, U Adelaide, La Trobe, INRA (France) and U Tokyo. With > 8500 citations, Prof Chapman is currently in the top 1% of authors cited in the ESI fields of Plant and Animal Sciences and in Agricultural Sciences.

A/Prof. Seth Cheetham is an ARC Discovery Early Career Award Fellow and Group Leader at the Australian Institute for Bioengineering and Nanotechnology. He is also the Deputy Director of the BASE facility, Australia's leading mRNA manufacturing hub. He completed his PhD at the University of Cambridge, supported by the Herchel Smith Research Studentship. Seth is a molecular biologist and geneticist with a focus on mRNA drugs, synthetic biology and epigenetics. He has authored 25 publications, in some of the most influential molecular biology journals including Science, Molecular Cell, Nature Reviews Genetics , Genome Biology and Nature Structural and Molecular Biology. His work has attracted > $15M including back-to-back NHMRC and ARC Fellowships. In 2021 Seth was awarded the Genetics Society of Australasia Alan Wilton ECR awarded for his research in the field of RNA and epigenetics.

Our lab aims to test fundamental hypotheses in genetics and evolutionary biology. Principally, we are interested the relationship between genotypic and phenotypic change during adaptive evolution. This line of inquiry requires an understanding of both the type of selection acting on traits as they evolve and ultimately the functional polymorphisms available for selection to act upon. We presently use both native and exotic species of Drosophila in our work but also undertake collaborative study in other organisms that represent examples of recurring ecological and evolutionary phenomena. We are equipped to use a broad range of techniques in our investigations including experimental evolution, field-based selection studies, quantitative genetics, molecular population genetics, genomics and advanced quantitative methods in statistics and computational biology. The broad range of techniques available to our group provides students with a unique opportunity to broaden their skill sets as they address fundamental questions.

An ecologist by training – I hold a B.Sc. (Hons) in Marine Ecology from the University of North Carolina, Wilmington and a Ph.D. in Ecological Modelling from Griffith University. I am broadly interested in exploring new ways to (1) understand how natural communities are formed and (2) predict how they will change over time. As an Amplify Fellow at UQ, my current research focuses on developing computational tools and adapting techniques from epidemiology and statistical forecasting to study how organisms and ecosystems respond to environmental change. This work is being applied to investigate natural dynamics for a range of natural systems including host-parasite interactions, wildlife populations and veterinary diseases.

I am an active member of the R community and have written and/or maintain several popular R packages. For example, I’m a lead developer on the MRFcov package for multivariate conditional random fields analyses. I also wrote the mvgam R package for fitting dynamic Generalised Additive Models to analyse and forecast multivariate ecological time series, and I regularly provide training seminars and workshops to help researchers learn techniques in ecological data analysis.

I am currently seeking Honours and PhD candidates with interests and/or skills in veterinary epidemiology, spatial / spatiotemporal modeling and quantitative ecology.